891785-18-5

Basic information

• Product Name: 3-(Benzyloxy)-5-broMo-2-chloropyridine
• Synonyms: 3-(Benzyloxy)-5-broMo-2-chloropyridine;5-bromo-2-chloro-3-benzyloxypyridine
• CAS NO: 891785-18-5
• Molecular Formula: C₁₂H₉BrClNO
• Molecular Weight: 298.56296
• Mol File: 891785-18-5.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 3-(Benzyloxy)-5-broMo-2-chloropyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(Benzyloxy)-5-broMo-2-chloropyridine(891785-18-5)
• EPA Substance Registry System: 3-(Benzyloxy)-5-broMo-2-chloropyridine(891785-18-5)

Safety Data

• Hazardous Substances Data: 891785-18-5(Hazardous Substances Data)

Usage

General Description

3-(Benzyloxy)-5-bromo-2-chloropyridine is a chemical compound with the molecular formula C12H9BrClNO. It is a pyridine derivative with a bromo and chloro substituents on the 5th and 2nd position, respectively, and a benzyl ether group at the 3rd position. 3-(Benzyloxy)-5-broMo-2-chloropyridine is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. It has a wide range of applications in organic synthesis and is known for its high selectivity and reactivity in various chemical reactions. 3-(Benzyloxy)-5-bromo-2-chloropyridine is an important building block in the synthesis of various biologically active compounds and is widely used in medicinal and agricultural research.

InChI:InChI=1S/C12H9BrClNO/c13-10-6-11(12(14)15-7-10)16-8-9-4-2-1-3-5-9/h1-7H,8H2

Upstream product

• 100-51-6 benzyl alcohol 
• 286946-77-8 5-bromo-2-chloro-3-hydroxypyridine 
• 100-39-0 benzyl bromide 
• 24016-03-3 2-amino-3-benzyloxypyridine 
• 754230-78-9 3-(benzyloxy)-5-bromopyridine-2-amine 
• 625-92-3 3,5-dibromopyridine 
• 552330-34-4 5-bromo-3-(benzyloxy)pyridine N-oxide 
• 130722-95-1 3-(benzyloxy)-5-bromopyridine 

Downstream Products

• 1314026-59-9 ethyl 3-amino-6-(3-{[(3-chlorophenyl)amino]carbonyl}phenyl)furo[3,2-b]pyridine-2-carboxylate 
• 1314026-60-2 ethyl 3-amino-6-(3-{[(3-fluorophenyl)amino]carbonyl}phenyl)furo[3,2-b]pyridine-2-carboxylate 
• 1314026-61-3 ethyl 3-amino-6-(3-{[(3-biphenyl)amino]carbonyl}phenyl)furo[3,2-b]pyridine-2-carboxylate 
• 1314026-62-4 ethyl 3-amino-6-(3-{[(4-chlorophenyl)amino]carbonyl}phenyl)furo[3,2-b]pyridine-2-carboxylate 
• 1314026-63-5 ethyl 3-amino-6-(3-{[(4-fluorophenyl)amino]carbonyl}phenyl)furo[3,2-b]pyridine-2-carboxylate 
• 1314026-64-6 ethyl 3-amino-6-(3-{[(4-biphenyl)amino]carbonyl}phenyl)furo[3,2-b]pyridine-2-carboxylate 
• 1314026-65-7 ethyl 3-amino-6-(4-{[(3-chlorophenyl)amino]carbonyl}phenyl)furo[3,2-b]pyridine-2-carboxylate 
• 1314026-66-8 ethyl 3-amino-6-(4-{[(3-biphenyl)amino]carbonyl}phenyl)furo[3,2-b]pyridine-2-carboxylate 
• 1314026-67-9 ethyl 3-amino-6-(4-{[(4-biphenyl)amino]carbonyl}phenyl)furo[3,2-b]pyridine-2-carboxylate 
• 1314026-68-0 3-amino-6-(3-{[(3-chlorophenyl)amino]carbonyl}phenyl)-N-methylfuro[3,2-b]pyridine-2-carboxamide 
• 1314026-69-1 3-amino-6-(3-{[(3-fluorophenyl)amino]carbonyl}phenyl)-N-methylfuro[3,2-b]pyridine-2-carboxamide 
• 1314026-70-4 3-amino-6-(3-{[(3-biphenyl)amino]carbonyl}phenyl)-N-methylfuro[3,2-b]pyridine-2-carboxamide 
• 1314026-71-5 3-amino-6-(3-{[(4-chlorophenyl)amino]carbonyl}phenyl)-N-methylfuro[3,2-b]pyridine-2-carboxamide 
• 1314026-72-6 3-amino-6-(3-{[(4-fluorophenyl)amino]carbonyl}phenyl)-N-methylfuro[3,2-b]pyridine-2-carboxamide 

Relevant articles and documents

NITROGEN-CONTAINING HETEROARYL COMPOUND AND PHARMACEUTICAL USE THEREOF

The invention provides a compound having a GLUT9 inhibitory activity. The compound is of Formula [I] wherein each symbol is as defined in the specification, or a pharmaceutically acceptable salt thereof.

INHIBITORS OF CATECHOL O-METHYL TRANSFERASE AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS

The present invention relates to 4-pyridinone compounds which are inhibitors of catechol O-methyltransferase (COMT), and are useful in the treatment and prevention of neurological and psychiatric disorders and diseases in which COMT enzyme is involved. Th

Isoquinoline-pyridine-based protein kinase B/Akt antagonists: SAR and in vivo antitumor activity

The structure-activity relationships of a series of isoquinoline-pyridine-based protein kinase B/Akt antagonists have been investigated in an effort to improve the major short-comings of the lead compound 3, including poor pharmacokinetic profiles in several species (e.g., mouse iv t1/2 = 0.3 h, po F = 0%). Chlorination at C-1 position of the isoquinoline improved its pharmacokinetic property in mice (iv t1/2 = 5.0 h, po F = 51%) but resulted in >500-fold drop in potency. In a mouse MiaPaCa-2 xenograft model, an amino analog 10y significantly slowed the tumor growth, however was accompanied by toxicity.